Striving to set the new standard of care for interventional pulmonary embolism treatment. Improving patient safety through data driven innovations. #FlowMedical
We’re excited to share enrollment for HI-PEITHO is now complete! With 544 patients enrolled across 72 sites in the United States in Europe, this landmark trial compares EKOS (Ultrasound Assisted Thrombolysis) with Anticoagulation vs Anticoagulation Alone in the treatment of intermediate-high risk PE patients. The study was a collaboration between The PERT Consortium, University Medical Center Mainz, and Boston Scientific. We extend our congratulations to all investigators and enrollment sites involved in this one-of-a-kind trial that will inform strategies for PE treatment around the world.#pe #pulmonaryembolism #hipeitho @bostonsci @bsc_pi
Learn more about HI-PEITHO: https://t.co/LbWU5Z3RkM
🌟Startup Spotlight: @GoFlowMedical
Founded by physicians out of @UChicago, Flow Medical is developing a catheter-based device for the treatment of pulmonary embolism (PE) that avoids the use of thrombolytics.
🧵
Built with clinical insight and supported by @polskycenter -- @GoFlowMedical is progressing toward first-in-human use.
Learn more about Flow Medical’s solution and their differentiated strategy for addressing Pulmonary Embolism:
https://t.co/pX4rnRr3JZ
Chicago’s deep tech momentum is no accident; it’s the result of strategic investment and belief in research-led innovation.
@HarperCventures is MFV’s commitment in action:
Backing frontier technology & founders -- shaping tomorrow’s breakthroughs.
https://t.co/kFeFFEKhOu
#SIRS_2025
A remarkable event unfolded, attracting a substantial audience!
PERT Call Simulation
The event commenced with a robust series of multidisciplinary dialogues, showcasing a panel of esteemed experts from Interventional Radiology, Intensive Care, Thrombosis Medicine, and Pulmonology. They delved into the latest updates on initiating PERT, current evidence, risk stratification, and the pivotal role of CETPH in Interventional Radiology.
Dr. Osman Ahmed @TheRealDoctorOs hailing from the @UChicagoMed , enriched the discourse with his invaluable perspectives.
#Riyadh
#IR #SIRS
#SaudiArabia
Normotensive shock in acute PE is more common than you think! A full RHC prior to PE intervention will save you from an “unexpected” crashing patient. Also, large clot burden does not always equal low cardiac output! @SandeepNathanMD@TheRealDoctorOs@UChicagoCardio
In this episode of the #DeviceTalksWeekly podcast, @GoFlowMedical CEO Jennifer Fried tells Host Tom Salemi the story of the #MedTech startup that recently closed on a $5M seed round. The story checks all the boxes of a great MedTech story.
LISTEN HERE: https://t.co/3BclMCcLVE
In this episode of the #DeviceTalksWeekly podcast, @GoFlowMedical CEO Jennifer Fried tells Host Tom Salemi the story of the #MedTech startup that recently closed on a $5M seed round. The story checks all the boxes of a great MedTech story.
LISTEN HERE: https://t.co/TQOVzYINZz
@IBM@UChicago 2// Flow Medical raises $5M seed round to tackle blood clots with a game-changing catheter device. Backed by UChicago Medicine’s new venture fund, this innovation is poised to save lives. #Polsky10@UChicagoMed@GoFlowMedical >> https://t.co/RSi5z2PwaU
#ICYMI: Chicago-based #startup@GoFlowMedical is combining insights from interventional #cardiology and radiology to improve catheter-delivered thrombolysis to treat pulmonary embolisms: https://t.co/heYjPw8mWl
VCs remain cautious about #digitalhealth investments despite evidence of a market rebound; @GoFlowMedical's new catheter-delivered approach to treat pulmonary embolisms; and a look at some of the emerging innovators in #heartfailure: https://t.co/YQ02DrjN8X